Mads Bastrup Israelsen
Post doc, PhD, MD
Post doc researcher and clinical hepatologist with a PhD in alcohol-related liver disease (2020). His main research interests are alcohol-related liver disease, prognostic markers of fatty liver disease, the gut-liver axis and complications to cirrhosis. He is involved in several clinical studies and the principal investigator of the Rifaximin Study at Odense Liver Research Centre.